zarxio The FDA has approved a supplemental Biologics License Application (sBLA) for Zarxio (filgrastim-sndz; Sandoz) to update the Warnings and Precautions section of the drug label. The Food and Drug ...
These figures underscore a significant growth trajectory for the Dual Chamber Prefilled Syringes Market, reflecting growing demand for advanced drug delivery systems, especially in biologics, vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results